Mesenchymal Stem Cells + Hyaluronan
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
36
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Recovery Following Partial Medial Meniscectomy
Conditions
Recovery Following Partial Medial Meniscectomy
Trial Timeline
Sep 1, 2005 → Apr 1, 2008
NCT ID
NCT00225095About Mesenchymal Stem Cells + Hyaluronan
Mesenchymal Stem Cells + Hyaluronan is a phase 1/2 stage product being developed by Mesoblast for Recovery Following Partial Medial Meniscectomy. The current trial status is completed. This product is registered under clinical trial identifier NCT00225095. Target conditions include Recovery Following Partial Medial Meniscectomy.
Hype Score Breakdown
Clinical
13
Activity
8
Company
5
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00225095 | Phase 1/2 | Completed |
Competing Products
3 competing products in Recovery Following Partial Medial Meniscectomy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| BAY207543 (Bepanthol, Bepantol® Derma Spray) | Bayer | Approved | 82 |
| BAY207543 (Bepanthol, Bepantol® Derma Spray) | Bayer | Approved | 82 |
| Chondrogen + Chondrogen + Placebo | Mesoblast | Phase 1/2 | 36 |